Skip to content

Computer-assisted surgery system for adrenal vein sampling in the diagnosis and treatment guidance of subtype diagnosis of primary aldosteronism

Computer-assisted surgery system for adrenal vein sampling in the diagnosis and treatment guidance of subtype diagnosis of primary aldosteronism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090078
Enrollment
Unknown
Registered
2024-09-24
Start date
2024-09-24
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism

Interventions

Experiment group:Operator completed the surgery using a computer-assisted surgical system
Control group:Operator completed the surgery without a computer-assisted surgical system

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Hypertensive patients aged 18 to 70 years. 2.CT shows adrenal nodules or adenomas = 1 cm. 3.ARR = 30 (ng/dL)/(ng/mL/h) or ARR = 3.7 (ng/dL)/(mU/L). 4.At least one positive captopril suppression test. 5.Obtained informed consent.

Exclusion criteria

Exclusion criteria: 1.Renal hypertension, renovascular hypertension, and adrenal hypertension. 2.Patients who have recently experienced a state of stress, such as infection, trauma, and surgery, as well as those with a history of severe heart disease, liver and kidney dysfunction, and cardiovascular disease. 3.Patients eating corticosteroids, glycyrrhizin preparations, or oral contraceptives. 4.Patients with active malignant tumors. 5.Patients with a history of adrenalectomy or adrenal cortical insufficiency. 6.Patients with familial primary aldosteronism. 7.Patients unsuitable for surgery, such as those with heart failure classified as New York Heart Association (NYHA) class III or IV, severe anemia (hemoglobin < 60 g/L), stroke or acute coronary syndrome within the last three months, severe ascites and liver cirrhosis, and estimated glomerular filtration rate (eGFR) < 30(mL/min/1.73m²)..

Design outcomes

Primary

MeasureTime frame
aldosterone;cortisol;

Secondary

MeasureTime frame
operation time;contrast agent volume;Intraoperative access attempts;

Countries

China

Contacts

Public Contactshufa li

The Affiliated Hospital of Qingdao University

shufali@qdu.edu.cn+86 138 5321 6301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026